皓元医药 (688131)

Shanghai Haoyuan Chemexpress Co., Ltd.

KSH

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 734059.07
  • Circulating A-Shares(W): 734059.07
  • Earnings Per Share(RMB): 1.23
  • Net Assets Per Share(RMB): 5.67
  • Operating Revenue(W RMB): 1345261.60
  • Total Profit(W RMB): 1345261.60
  • **Net Profit Attributable to Parent(W RMB) **: 1345261.60
  • Net Profit Growth Rate(%): -55.89
  • Weighted Return on Equity(%): 4.6500
  • Operating Cash Flow Per Share(RMB): 1.23
  • Undistributed Profit Per Share(RMB): 1.23
  • Capital Reserve Per Share(RMB): 1.23

2. Main Business

The main business covers:

  • New energy vehicle manufacturing and sales
  • Intelligent transportation system R&D
  • Fuel cell technology development
  • Autonomous driving solutions

3. Company Basic Information

  • Company Name: Dongfeng Automobile Co., Ltd.
  • Listing Date: 2001-05-18
  • Industry: Automobile Manufacturing
  • Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
  • Website: https://www.dongfeng.com.cn/
  • Company Profile: The company was established with Beijing Capital Venture Group as the main sponsor....

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Shanghai Anxu Information Technology Co., Ltd. General Legal Person 6808.29 32.10
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 860.68 4.06
3 Shanghai Chenxiao Enterprise Management Consulting Center (Limited Partnership) General Legal Person 836.92 3.95
4 China Europe Healthcare Hybrid Securities Investment Fund Class A Fund 725.73 3.42
5 Shanghai Kangfeng Investment Management Co., Ltd. General Legal Person 644.83 3.04
6 Shanghai Chenmai Enterprise Management Center (Limited Partnership) General Legal Person 548.80 2.59
7 Xinyu Chengzhongtang Investment Management Center (Limited Partnership) General Legal Person 406.52 1.92
8 Ningbo Chenxi Investment Partnership (Limited Partnership) General Legal Person 274.40 1.29
9 China Europe Medical Innovation Equity Securities Investment Fund Class A Fund 220.63 1.04
10 China Universal Healthcare Hybrid Securities Investment Fund Fund 141.03 0.66

5. Concept Sectors

  • Convertible Bonds
  • Artificial Intelligence
  • CXO Concept
  • Innovative Drugs
  • Weight Loss Drugs
  • Synthetic Biology
  • AI Healthcare
  • Margin Trading
  • High-Performance Stocks
  • Specialized, Refined, Unique, and New Enterprises
  • SSE 380
  • STAR Market Biotech
  • STAR Market 200

Remarks

  • Data update date: 2025-09-30
  • Data source: Public market information